Anthem
group companies

Driven by drug discovery
          moving towards affordable biotechnology

Anthem
group companies

Driven by Drug Discovery
          moving towards affordable biotechnology

Anthem
group companies

Driven by Drug Discovery
          moving towards affordable biotechnology

Anthem
group companies

Driven by Drug Discovery
          moving towards affordable biotechnology

Anthem
group companies

Driven by Drug Discovery
          moving towards affordable biotechnology

Anthem
group companies

Driven by Drug Discovery
          moving towards affordable biotechnology

Transplant Portfolio

Keygraf ® 0.5/1.0/2.0

Composition:
Each hard gelatin capsule contains:
Tacrolimus 0.5 mg / 1.0 mg / 2.0 mg

Description:
Keygraf (Tacrolimus) is a macrolide immunosuppressive drug. It is obtained from Streptomyces tsukubaensis.

Indication:
Keygraf (Tacrolimus) is used as a prophylaxis treatment to prevent the transplant organ (graft) rejection in solid organ transplantation along with other immunosuppressive drugs.

Dosage & Administration:
Prescribed dose of Keygraf should be taken in an empty stomach at least 1 hour before food in the morning and night for better absorption.

Storage:

  • Keep the medicine out of reach of children.
  • Store in a cool, dry and dark place. Protect from direct sun light.
  • Do not freeze / Do not keep in refrigerator.

Keygraf

Keycept ® 250/500

Keycept 250

Composition:
Each hard gelatin capsule contains:
Mycophenolate Mofetil 250 mg

Keycept 500

Composition:
Each film coated tablet contains:
Mycophenolate Mofetil 500 mg

Description:
Keycept (Mycophenolate Mofetil) is an ester prodrug of mycophenolic acid (MPA). After oral administration Keycept is metabolized into active drug mycophenolic acid.

Indication:

  • Keycept is used as a prophylaxis treatment to prevent the transplant organ (graft) rejection in solid organ transplantation along with other immunosuppressive drugs.
  • Keycept is used in the treatment of Lupus Nephritis / Systemic Lupus Erythematosus (SLE)
  • Keycept is used in the treatment of Nephrotic Syndrome.

Dosage & administration:
Prescribed dose of Keycept should be taken in an empty stomach at least 30-60 mins before food in the morning and night for better absorption.

Storage:

  • Keep the medicine out of reach of children.
  • Store in a cool, dry and dark place. Protect from direct sun light.
  • Do not freeze / Do not keep in refrigerator.

Keycept S 250
Keycept S 500

Keycept S ® 360

Composition:
Each enteric coated tablet contains:
Mycophenolate Sodium 360 mg

Description:
Keycept S (Mycophenolate Sodium) is an enteric coated salt form of mycophenolic acid (MPA). After oral administration Keycept S is metabolized into active drug mycophenolic acid.

Indication:

  • Keycept S is used as a prophylaxis treatment to prevent the transplant organ (graft) rejection in solid organ transplantation along with other immunosuppressive drugs.
  • Keycept S is used in the treatment of Systemic Lupus Erytheomatosus (SLE)
  • Keycept S is used in the treatment of Nephrotic Syndrome.

Dosage & Administration:
Prescribed dose of Keycept S should be taken in an empty stomach at least 30-60 mins before food in the morning and night for better absorption.

Storage:

  • Keep the medicine out of reach of children.
  • Store in a cool, dry and dark place. Protect from direct sun light.
  • Do not freeze / Do not keep in refrigerator.

Keycept S 360

CMVIgone ® 450

Composition:
Each film coated tablet contains:
Valganciclovir Hydrochloride eq. to Valganciclovir 450 mg

Description:
CMVIgone (Valganciclovir) is a an "antiviral" drug.

Indication:

  • CMVIgone is used in the treatment of cytomegalovirus (CMV) disease in solid organ transplant recipients.
  • CMVIgone is used to prevent the cytomegalovirus (CMV) infection in solid organ (kidney/liver/heart/pancreas) transplant recipients.
  • CMVIgone used in the treatment of cytomegalovirus (CMV) retinitis in patients who have acquired immunodeficiency syndrome (AIDS).

Dosage & administration:

  • Prescribed dose of CMVIgone should be taken after or along with food for better absorption and minimized gastro intestinal disturbances.
  • For prevention of CMV infection, generally CMVIgone prescribed for 3 months from the time of transplantation.

Storage:

  • Keep the medicine out of reach of children.
  • Store in a cool, dry and dark place. Protect from direct sun light.
  • Do not freeze / Do not keep in refrigerator.

CMVIgone 450

SIROtrend

Composition:
Each film coated tablet contains:
Sirolimus 1.0 mg

Description:
SIROtrend (Sirolimus) is a macrolide immunosuppressive drug. It is obtained from Streptomyces hygroscopicus.

Indication:
SIROtrend is used as a prophylaxis treatment to prevent the transplant organ (graft) rejection in solid organ transplantation along with other immunosuppressive drugs.

Dosage & administration:

  • Prescribed dose of SIROtrend should be taken in an empty stomach at least 1 hour before food or 2 hours after food in the morning for better absorption.
  • If patient is taking cyclosporine, Cyclosporine has to be taken first and 4 hours later SIROtrend has to be taken to avoid drug interactions and toxicities.

Storage:

  • Keep the medicine out of reach of children.
  • Store in a cool, dry and dark place. Protect from direct sun light.
  • Do not freeze / Do not keep in refrigerator.

SIROtrend
Accreditations
QUICK CONTACT
Name
Email ID
Contact Number
Message
CONNECT WITH US
WE ARE HERE